Dr. Robby Singh, M.D.
What this data tells you about Dr. Singh
Dr. Robby Singh is a cardiovascular disease in Brandon, FL, with 12 years in practice. Based on federal Medicare data, Dr. Singh performed 3,343 Medicare services across 2,260 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $9,641 from 43 pharmaceutical and/or device companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 536 | $11 | $42 |
| Office visit, established patient (30-39 min) | 518 | $92 | $260 |
| Hospital follow-up visit, high complexity | 263 | $94 | $200 |
| Office visit, established patient (20-29 min) | 243 | $64 | $129 |
| Injection, dipyridamole, per 10 mg | 239 | $3 | $18 |
| Hospital follow-up visit, moderate complexity | 201 | $63 | $139 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 181 | $350 | $794 |
| Initial hospital admission, high complexity | 161 | $136 | $388 |
| Echocardiogram, transthoracic | 142 | $139 | $403 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 115 | $47 | $216 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 102 | $194 | $350 |
| Regadenoson injection (Lexiscan) for heart stress test | 92 | $27 | $130 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 91 | $327 | $722 |
| New patient office visit (45-59 min) | 75 | $120 | $339 |
| Transitional care management services for problem of high complexity | 51 | $211 | $490 |
| Ultrasonic guidance for blood vessel access | 46 | $12 | $28 |
| Ultrasound of both sides of head and neck blood flow | 45 | $131 | $468 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $10 | $25 |
| Ultrasound of heart, follow-up | 36 | $19 | $194 |
| Injection, aminophyllin, up to 250 mg | 30 | $6 | $15 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 27 | $180 | $570 |
| Cardiac catheterization | 23 | $195 | $692 |
| Transitional care management services for problem of at least moderate complexity | 23 | $158 | $370 |
| Ultrasound study of arm and leg arteries | 21 | $55 | $236 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 18 | $137 | $368 |
| Ultrasound of heart with probe in esophagus to assess heart pump function | 13 | $80 | $230 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 12 | $128 | $600 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Singh is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with electrocardiogram (ekg), 12-lead?
Does Dr. Singh receive payments from pharmaceutical companies?
How do Dr. Singh's costs compare to other cardiovascular diseases in Brandon?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology